Orally Disintegrating Antipsychotics May Promote Compliance and Adherence in Patients With Schizophrenia
J Clin Psychiatry 2005;66(11):1493-1494 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
Kane et al., in their recent (January 2005) CME activity
“Optimizing Pharmacotherapy to Maximize Outcome in
recommend using a long-acting depot injection
in patients who fail to adhere to antipsychotic treatment.
While depot medications ensure compliance, they may not foster
certain aspects of the doctor-patient relationship, and even
with depot medication, about 25% of patients stop keeping
scheduled appointments and no longer receive depot injections
within 1 year after starting treatment.2
medications may be associated with an increased risk for prolonged